Be part of the knowledge.™

Evolving Treatment of Inflammatory Bowel Disease

Media Formats

ReachMD Healthcare Image

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details

Presenters

Overview
Steroids used to be the standard treatment for inflammatory bowel disease. But now biologic and immunosuppresive therapies are often used. How can we increase the efficacy of these medications? What combinations work best? Dr. Richard Fedorak, professor of medicine in the division of gastroenterology at the University of Alberta in Canada, discusses IBD treatments with host Dr. Jay Goldstein.

Jay Goldstein, MD

Jay Goldstein, MD

Richard Fedorak, MD

Richard Fedorak, MD

Recommended

Details

Presenters

Overview
Steroids used to be the standard treatment for inflammatory bowel disease. But now biologic and immunosuppresive therapies are often used. How can we increase the efficacy of these medications? What combinations work best? Dr. Richard Fedorak, professor of medicine in the division of gastroenterology at the University of Alberta in Canada, discusses IBD treatments with host Dr. Jay Goldstein.

Jay Goldstein, MD

Jay Goldstein, MD

Richard Fedorak, MD

Richard Fedorak, MD

Program Chapters

Segment Chapters

Playlist:

Recommended

Updates From the 7th World Symposium Task Force

Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies

Diagnosis and Management of Metastatic PDAC

TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management

Partnering with Patients: Building Effective Communication and Support in HF Care

Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA

Clinical Conundrums in ARIA: Differential Diagnoses and Potential Pitfalls in ARIA Evaluation

The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC